Intelligence / BPC-157

BPC-157

Prescription Only
Tissue Repair
Schedule
S4
Prescription Only
Enforcement
Stable
Low Risk
Providers
18
Access: Clear
Key Facts
Schedule 4 - Prescription Only
15 amino acid synthetic peptide
18 identified Australian providers
Stable regulatory environment
Widely compounded in Australia

Overview

BPC-157 is a synthetic peptide consisting of 15 amino acids, derived from a protein found in human gastric juice. It is one of the most widely prescribed peptides in Australia, available through compounding pharmacies with a valid prescription.

Australian Scheduling

Classified as Schedule 4 (Prescription Only) under the Poisons Standard. Requires a valid prescription from an AHPRA-registered medical practitioner. No anticipated scheduling changes for 2026-2027.

Access Pathway

Available through most telehealth peptide clinics and compounding pharmacies nationally. This is one of the most accessible prescription peptides in the Australian market, with 18 identified providers offering consultations.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

News & Updates20 items
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis
Appl Biochem Biotechnol29 Aug 2026
Meet the doctors prescribing experimental peptides such as TB-500 and BPC-157 to athletes and executives
Australian Financial Review16 Aug 2026
DIY peptide injections are risky, and people may make serious mistakes when administering them
The Conversation7 Aug 2026
A clinical trial to evaluate BPC-157 peptide gummies for inflammation, physical performance and recovery
ClinicalTrials.gov7 Aug 2026
Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society29 July 2026
Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.
The Analyst27 July 2026
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
Joint diseases and related surgery23 July 2026
FDA panel votes to loosen restrictions for controversial peptides
BBC News23 July 2026
Unapproved peptide product promoters and suppliers are put on notice
TGA20 July 2026
Fabrication and characterization of biocompatible BPC-157 based chitosan hydrogel.
3 Biotech6 July 2026
Unapproved SARMs found to be significantly underdosed
TGA6 July 2026
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review
Current sports medicine reports1 July 2026
TGA and Chief Medical Officer issue joint statement on unapproved peptide products
TGA20 June 2026
Concerns regarding the public health risks associated with unapproved peptide products
TGA19 June 2026
Peptide Therapies in Thyroid Health: Emerging Applications in Endocrine and Immune Modulation.
Integrative medicine (Encinitas, Calif.)1 June 2026
Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach.
Pharmaceuticals (Basel, Switzerland)30 May 2026
BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase.
International journal of molecular sciences30 May 2026
Protective effects of BPC 157 on liver, kidney, and lung distant organ damage in rats with experimental lower-extremity ischemia-reperfusion injury
Sci Rep28 May 2026
Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury.
Scientific reports28 May 2026
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers.
Pharmaceutics20 May 2026

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.